Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 63.06 M67.52 M61.66 M56.41 M66.78 M 252.38 M Research & development ————— — Operating income 206.26 M304.17 M276.12 M172 M312.23 M 1.06 B Non-Operating Income, Total 4.98 M20.29 M9.17 M26.46 M8.6 M 64.53 M Interest expense, net of interest capitalized 25 K17 K6 00060 K0 83 K Non-Operating Income, excl. Interest Expenses 4.87 M21.42 M8.54 M24.68 M9.83 M 64.47 M Unusual income/expense 92 K-1.14 M627 K1.72 M-1.23 M -30 K Pretax income 210.76 M327.34 M284.15 M198.69 M320.94 M 1.13 B Equity in earnings -458 K2.9 M3.7 M2.44 M115 K 9.15 M Taxes 51.48 M78.86 M73.9 M43.12 M79.56 M 275.43 M Non-controlling/minority interest 1.85 M2.56 M2.13 M1.86 M2.37 M 8.91 M After tax other income/expense ————— — Net income before discontinued operations 157.43 M245.92 M208.12 M153.71 M239.02 M 846.78 M Discontinued operations ————— — Net income 157.43 M245.92 M208.12 M153.71 M239.02 M 846.78 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 157.43 M245.92 M208.12 M153.71 M239.02 M 846.78 M Basic earnings per share (Basic EPS) 0.711.130.950.71.09 3.88 Diluted earnings per share (Diluted EPS) 0.691.110.940.691.08 3.82 Average basic shares outstanding 221.48 M217.49 M218.23 M218.95 M218.19 M — Diluted shares outstanding 226.14 M221.88 M221.86 M222.98 M221.82 M — EBITDA 269.34 M304.4 M328.17 M172.04 M343.14 M 1.15 B EBIT 252.22 M286.5 M311.56 M155.11 M326.49 M 1.08 B Cost of revenue 728.18 M785.19 M738.15 M714.56 M834.56 M 3.07 B Other cost of goods sold 728.18 M785.19 M738.15 M714.56 M834.56 M 3.07 B Depreciation & amortization (cash flow) 17.12 M17.91 M16.61 M16.93 M16.65 M 68.09 M